Recently, high expression of several of these PSM genes (e.g. PSMA1, PSMB4, and PSMD2) has been correlated with poor prognosis in a number of cancer types, including breast-, lung-, and gastric cancer [76–78]. This evidence concerns the gene PSMA1 and cancer.